ArticleGalen medical journal2025
Effects of Preanhepatic Glucose-Insulin Infusion on Metabolic and Hemodynamic Outcomes in Liver Transplantation: A Randomized Clinical Trial : Preanhepatic Glucose-Insulin Infusion and Liver Transplantation.
Article in Galen medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Liver transplantation is a complex procedure requiring meticulous perioperative management to optimize outcomes. The administration of glucose-insulin solutions during the preanhepatic phase may influence hemodynamic and metabolic stability. This study aimed to evaluate the effects of dextrose-insulin infusion on hemodynamic, metabolic, and clinical outcomes in liver transplant recipients. Materials and Methods: A randomized, double-blinded clinical trial was conducted on 88 patients (1:1 allocation) undergoing liver transplantation at Taleghani Hospital, Iran. The intervention group received dextrose 50% (1g/kg) and insulin (1u/kg), while the control group received normal saline. Hemodynamic parameters (cardiac output, vascular resistance), metabolic markers (glucose, potassium, lactate), and clinical outcomes (hospital stay, complications) were assessed across preanhepatic, anhepatic, and reperfusion phases. Statistical analysis was performed using SPSS v27.0. Results: The intervention group demonstrated significantly higher cardiac output (6.95±1.66 vs. 5.56±2.02 L/min, P0.001) and lower inotropic requirements (65.9% vs. 88.6%, P=0.018) during the anhepatic phase. Postoperatively, the intervention group had reduced ALT (P=0.038), AST (P=0.019), bilirubin (P=0.021), BNP (P=0.002), and lactate (P0.001). No differences were observed in hospital stay, ICU duration, or complication rates. Conclusion: Dextrose-insulin administration during liver transplantation improves intraoperative hemodynamics and reduces postoperative metabolic stress without increasing adverse events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.